metformin has been researched along with Cancer-Associated Pain in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the function of aspirin use in pancreatic cancer largely remains unknown." | 2.53 | Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. ( Dai, JJ; Gu, DN; Huang, Q; Jiang, MJ; Tian, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, MJ | 1 |
| Dai, JJ | 1 |
| Gu, DN | 1 |
| Huang, Q | 1 |
| Tian, L | 1 |
1 review available for metformin and Cancer-Associated Pain
| Article | Year |
|---|---|
Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Cancer Pain; Humans; Metformin; Pancreatic Neoplasms | 2016 |